The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global End Stage Renal Disease (ESRD) Therapy Market Research Report 2025

Global End Stage Renal Disease (ESRD) Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1688401

No of Pages : 90

Ask Your Query
Synopsis
End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.

The global End Stage Renal Disease (ESRD) Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for End Stage Renal Disease (ESRD) Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding End Stage Renal Disease (ESRD) Therapy.

Report Scope

The End Stage Renal Disease (ESRD) Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global End Stage Renal Disease (ESRD) Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the End Stage Renal Disease (ESRD) Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Fresenius

DaVita

Baxter

Nipro

B. Braun

Asahi Kasei

Nikkiso

WEGO

Newsol

Mayo Clinic

Guangdong Biolight

Medtronic

Sanxin Medtec

Jafron Biomedical

SWS Hemodialysis Care

Tianyi Medical

Segment by Type

Hemodialysis

Peritoneal Dialysis

Kidney Transplantation

Segment by Application

Hospitals

Kidney Dialysis Centers

At Homes

Others

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of End Stage Renal Disease (ESRD) Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global End Stage Renal Disease (ESRD) Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Hemodialysis

1.2.3 Peritoneal Dialysis

1.2.4 Kidney Transplantation

1.3 Market by Application

1.3.1 Global End Stage Renal Disease (ESRD) Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Kidney Dialysis Centers

1.3.4 At Homes

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global End Stage Renal Disease (ESRD) Therapy Market Perspective (2019-2030)

2.2 End Stage Renal Disease (ESRD) Therapy Growth Trends by Region

2.2.1 Global End Stage Renal Disease (ESRD) Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 End Stage Renal Disease (ESRD) Therapy Historic Market Size by Region (2019-2024)

2.2.3 End Stage Renal Disease (ESRD) Therapy Forecasted Market Size by Region (2025-2030)

2.3 End Stage Renal Disease (ESRD) Therapy Market Dynamics

2.3.1 End Stage Renal Disease (ESRD) Therapy Industry Trends

2.3.2 End Stage Renal Disease (ESRD) Therapy Market Drivers

2.3.3 End Stage Renal Disease (ESRD) Therapy Market Challenges

2.3.4 End Stage Renal Disease (ESRD) Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top End Stage Renal Disease (ESRD) Therapy Players by Revenue

3.1.1 Global Top End Stage Renal Disease (ESRD) Therapy Players by Revenue (2019-2024)

3.1.2 Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share by Players (2019-2024)

3.2 Global End Stage Renal Disease (ESRD) Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by End Stage Renal Disease (ESRD) Therapy Revenue

3.4 Global End Stage Renal Disease (ESRD) Therapy Market Concentration Ratio

3.4.1 Global End Stage Renal Disease (ESRD) Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by End Stage Renal Disease (ESRD) Therapy Revenue in 2023

3.5 End Stage Renal Disease (ESRD) Therapy Key Players Head office and Area Served

3.6 Key Players End Stage Renal Disease (ESRD) Therapy Product Solution and Service

3.7 Date of Enter into End Stage Renal Disease (ESRD) Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 End Stage Renal Disease (ESRD) Therapy Breakdown Data by Type

4.1 Global End Stage Renal Disease (ESRD) Therapy Historic Market Size by Type (2019-2024)

4.2 Global End Stage Renal Disease (ESRD) Therapy Forecasted Market Size by Type (2025-2030)

5 End Stage Renal Disease (ESRD) Therapy Breakdown Data by Application

5.1 Global End Stage Renal Disease (ESRD) Therapy Historic Market Size by Application (2019-2024)

5.2 Global End Stage Renal Disease (ESRD) Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America End Stage Renal Disease (ESRD) Therapy Market Size (2019-2030)

6.2 North America End Stage Renal Disease (ESRD) Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2019-2024)

6.4 North America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe End Stage Renal Disease (ESRD) Therapy Market Size (2019-2030)

7.2 Europe End Stage Renal Disease (ESRD) Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe End Stage Renal Disease (ESRD) Therapy Market Size by Country (2019-2024)

7.4 Europe End Stage Renal Disease (ESRD) Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size (2019-2030)

8.2 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America End Stage Renal Disease (ESRD) Therapy Market Size (2019-2030)

9.2 Latin America End Stage Renal Disease (ESRD) Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2019-2024)

9.4 Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size (2019-2030)

10.2 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Fresenius

11.1.1 Fresenius Company Detail

11.1.2 Fresenius Business Overview

11.1.3 Fresenius End Stage Renal Disease (ESRD) Therapy Introduction

11.1.4 Fresenius Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.1.5 Fresenius Recent Development

11.2 DaVita

11.2.1 DaVita Company Detail

11.2.2 DaVita Business Overview

11.2.3 DaVita End Stage Renal Disease (ESRD) Therapy Introduction

11.2.4 DaVita Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.2.5 DaVita Recent Development

11.3 Baxter

11.3.1 Baxter Company Detail

11.3.2 Baxter Business Overview

11.3.3 Baxter End Stage Renal Disease (ESRD) Therapy Introduction

11.3.4 Baxter Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.3.5 Baxter Recent Development

11.4 Nipro

11.4.1 Nipro Company Detail

11.4.2 Nipro Business Overview

11.4.3 Nipro End Stage Renal Disease (ESRD) Therapy Introduction

11.4.4 Nipro Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.4.5 Nipro Recent Development

11.5 B. Braun

11.5.1 B. Braun Company Detail

11.5.2 B. Braun Business Overview

11.5.3 B. Braun End Stage Renal Disease (ESRD) Therapy Introduction

11.5.4 B. Braun Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.5.5 B. Braun Recent Development

11.6 Asahi Kasei

11.6.1 Asahi Kasei Company Detail

11.6.2 Asahi Kasei Business Overview

11.6.3 Asahi Kasei End Stage Renal Disease (ESRD) Therapy Introduction

11.6.4 Asahi Kasei Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.6.5 Asahi Kasei Recent Development

11.7 Nikkiso

11.7.1 Nikkiso Company Detail

11.7.2 Nikkiso Business Overview

11.7.3 Nikkiso End Stage Renal Disease (ESRD) Therapy Introduction

11.7.4 Nikkiso Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.7.5 Nikkiso Recent Development

11.8 WEGO

11.8.1 WEGO Company Detail

11.8.2 WEGO Business Overview

11.8.3 WEGO End Stage Renal Disease (ESRD) Therapy Introduction

11.8.4 WEGO Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.8.5 WEGO Recent Development

11.9 Newsol

11.9.1 Newsol Company Detail

11.9.2 Newsol Business Overview

11.9.3 Newsol End Stage Renal Disease (ESRD) Therapy Introduction

11.9.4 Newsol Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.9.5 Newsol Recent Development

11.10 Mayo Clinic

11.10.1 Mayo Clinic Company Detail

11.10.2 Mayo Clinic Business Overview

11.10.3 Mayo Clinic End Stage Renal Disease (ESRD) Therapy Introduction

11.10.4 Mayo Clinic Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.10.5 Mayo Clinic Recent Development

11.11 Guangdong Biolight

11.11.1 Guangdong Biolight Company Detail

11.11.2 Guangdong Biolight Business Overview

11.11.3 Guangdong Biolight End Stage Renal Disease (ESRD) Therapy Introduction

11.11.4 Guangdong Biolight Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.11.5 Guangdong Biolight Recent Development

11.12 Medtronic

11.12.1 Medtronic Company Detail

11.12.2 Medtronic Business Overview

11.12.3 Medtronic End Stage Renal Disease (ESRD) Therapy Introduction

11.12.4 Medtronic Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.12.5 Medtronic Recent Development

11.13 Sanxin Medtec

11.13.1 Sanxin Medtec Company Detail

11.13.2 Sanxin Medtec Business Overview

11.13.3 Sanxin Medtec End Stage Renal Disease (ESRD) Therapy Introduction

11.13.4 Sanxin Medtec Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.13.5 Sanxin Medtec Recent Development

11.14 Jafron Biomedical

11.14.1 Jafron Biomedical Company Detail

11.14.2 Jafron Biomedical Business Overview

11.14.3 Jafron Biomedical End Stage Renal Disease (ESRD) Therapy Introduction

11.14.4 Jafron Biomedical Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.14.5 Jafron Biomedical Recent Development

11.15 SWS Hemodialysis Care

11.15.1 SWS Hemodialysis Care Company Detail

11.15.2 SWS Hemodialysis Care Business Overview

11.15.3 SWS Hemodialysis Care End Stage Renal Disease (ESRD) Therapy Introduction

11.15.4 SWS Hemodialysis Care Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.15.5 SWS Hemodialysis Care Recent Development

11.16 Tianyi Medical

11.16.1 Tianyi Medical Company Detail

11.16.2 Tianyi Medical Business Overview

11.16.3 Tianyi Medical End Stage Renal Disease (ESRD) Therapy Introduction

11.16.4 Tianyi Medical Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

11.16.5 Tianyi Medical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details
List of Tables
List of Tables

Table 1. Global End Stage Renal Disease (ESRD) Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Hemodialysis

Table 3. Key Players of Peritoneal Dialysis

Table 4. Key Players of Kidney Transplantation

Table 5. Global End Stage Renal Disease (ESRD) Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global End Stage Renal Disease (ESRD) Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global End Stage Renal Disease (ESRD) Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global End Stage Renal Disease (ESRD) Therapy Market Share by Region (2019-2024)

Table 9. Global End Stage Renal Disease (ESRD) Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global End Stage Renal Disease (ESRD) Therapy Market Share by Region (2025-2030)

Table 11. End Stage Renal Disease (ESRD) Therapy Market Trends

Table 12. End Stage Renal Disease (ESRD) Therapy Market Drivers

Table 13. End Stage Renal Disease (ESRD) Therapy Market Challenges

Table 14. End Stage Renal Disease (ESRD) Therapy Market Restraints

Table 15. Global End Stage Renal Disease (ESRD) Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global End Stage Renal Disease (ESRD) Therapy Market Share by Players (2019-2024)

Table 17. Global Top End Stage Renal Disease (ESRD) Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease (ESRD) Therapy as of 2023)

Table 18. Ranking of Global Top End Stage Renal Disease (ESRD) Therapy Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by End Stage Renal Disease (ESRD) Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players End Stage Renal Disease (ESRD) Therapy Product Solution and Service

Table 22. Date of Enter into End Stage Renal Disease (ESRD) Therapy Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global End Stage Renal Disease (ESRD) Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share by Type (2019-2024)

Table 26. Global End Stage Renal Disease (ESRD) Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share by Type (2025-2030)

Table 28. Global End Stage Renal Disease (ESRD) Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share by Application (2019-2024)

Table 30. Global End Stage Renal Disease (ESRD) Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share by Application (2025-2030)

Table 32. North America End Stage Renal Disease (ESRD) Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe End Stage Renal Disease (ESRD) Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe End Stage Renal Disease (ESRD) Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe End Stage Renal Disease (ESRD) Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America End Stage Renal Disease (ESRD) Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 47. Fresenius Company Detail

Table 48. Fresenius Business Overview

Table 49. Fresenius End Stage Renal Disease (ESRD) Therapy Product

Table 50. Fresenius Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 51. Fresenius Recent Development

Table 52. DaVita Company Detail

Table 53. DaVita Business Overview

Table 54. DaVita End Stage Renal Disease (ESRD) Therapy Product

Table 55. DaVita Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 56. DaVita Recent Development

Table 57. Baxter Company Detail

Table 58. Baxter Business Overview

Table 59. Baxter End Stage Renal Disease (ESRD) Therapy Product

Table 60. Baxter Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 61. Baxter Recent Development

Table 62. Nipro Company Detail

Table 63. Nipro Business Overview

Table 64. Nipro End Stage Renal Disease (ESRD) Therapy Product

Table 65. Nipro Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 66. Nipro Recent Development

Table 67. B. Braun Company Detail

Table 68. B. Braun Business Overview

Table 69. B. Braun End Stage Renal Disease (ESRD) Therapy Product

Table 70. B. Braun Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 71. B. Braun Recent Development

Table 72. Asahi Kasei Company Detail

Table 73. Asahi Kasei Business Overview

Table 74. Asahi Kasei End Stage Renal Disease (ESRD) Therapy Product

Table 75. Asahi Kasei Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 76. Asahi Kasei Recent Development

Table 77. Nikkiso Company Detail

Table 78. Nikkiso Business Overview

Table 79. Nikkiso End Stage Renal Disease (ESRD) Therapy Product

Table 80. Nikkiso Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 81. Nikkiso Recent Development

Table 82. WEGO Company Detail

Table 83. WEGO Business Overview

Table 84. WEGO End Stage Renal Disease (ESRD) Therapy Product

Table 85. WEGO Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 86. WEGO Recent Development

Table 87. Newsol Company Detail

Table 88. Newsol Business Overview

Table 89. Newsol End Stage Renal Disease (ESRD) Therapy Product

Table 90. Newsol Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 91. Newsol Recent Development

Table 92. Mayo Clinic Company Detail

Table 93. Mayo Clinic Business Overview

Table 94. Mayo Clinic End Stage Renal Disease (ESRD) Therapy Product

Table 95. Mayo Clinic Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 96. Mayo Clinic Recent Development

Table 97. Guangdong Biolight Company Detail

Table 98. Guangdong Biolight Business Overview

Table 99. Guangdong Biolight End Stage Renal Disease (ESRD) Therapy Product

Table 100. Guangdong Biolight Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 101. Guangdong Biolight Recent Development

Table 102. Medtronic Company Detail

Table 103. Medtronic Business Overview

Table 104. Medtronic End Stage Renal Disease (ESRD) Therapy Product

Table 105. Medtronic Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 106. Medtronic Recent Development

Table 107. Sanxin Medtec Company Detail

Table 108. Sanxin Medtec Business Overview

Table 109. Sanxin Medtec End Stage Renal Disease (ESRD) Therapy Product

Table 110. Sanxin Medtec Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 111. Sanxin Medtec Recent Development

Table 112. Jafron Biomedical Company Detail

Table 113. Jafron Biomedical Business Overview

Table 114. Jafron Biomedical End Stage Renal Disease (ESRD) Therapy Product

Table 115. Jafron Biomedical Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 116. Jafron Biomedical Recent Development

Table 117. SWS Hemodialysis Care Company Detail

Table 118. SWS Hemodialysis Care Business Overview

Table 119. SWS Hemodialysis Care End Stage Renal Disease (ESRD) Therapy Product

Table 120. SWS Hemodialysis Care Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 121. SWS Hemodialysis Care Recent Development

Table 122. Tianyi Medical Company Detail

Table 123. Tianyi Medical Business Overview

Table 124. Tianyi Medical End Stage Renal Disease (ESRD) Therapy Product

Table 125. Tianyi Medical Revenue in End Stage Renal Disease (ESRD) Therapy Business (2019-2024) & (US$ Million)

Table 126. Tianyi Medical Recent Development

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

List of Figures

Figure 1. Global End Stage Renal Disease (ESRD) Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global End Stage Renal Disease (ESRD) Therapy Market Share by Type: 2023 VS 2030

Figure 3. Hemodialysis Features

Figure 4. Peritoneal Dialysis Features

Figure 5. Kidney Transplantation Features

Figure 6. Global End Stage Renal Disease (ESRD) Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global End Stage Renal Disease (ESRD) Therapy Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Kidney Dialysis Centers Case Studies

Figure 10. At Homes Case Studies

Figure 11. Others Case Studies

Figure 12. End Stage Renal Disease (ESRD) Therapy Report Years Considered

Figure 13. Global End Stage Renal Disease (ESRD) Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global End Stage Renal Disease (ESRD) Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global End Stage Renal Disease (ESRD) Therapy Market Share by Region: 2023 VS 2030

Figure 16. Global End Stage Renal Disease (ESRD) Therapy Market Share by Players in 2023

Figure 17. Global Top End Stage Renal Disease (ESRD) Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease (ESRD) Therapy as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by End Stage Renal Disease (ESRD) Therapy Revenue in 2023

Figure 19. North America End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America End Stage Renal Disease (ESRD) Therapy Market Share by Country (2019-2030)

Figure 21. United States End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe End Stage Renal Disease (ESRD) Therapy Market Share by Country (2019-2030)

Figure 25. Germany End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Share by Region (2019-2030)

Figure 33. China End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America End Stage Renal Disease (ESRD) Therapy Market Share by Country (2019-2030)

Figure 41. Mexico End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Share by Country (2019-2030)

Figure 45. Turkey End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Fresenius Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 48. DaVita Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 49. Baxter Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 50. Nipro Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 51. B. Braun Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 52. Asahi Kasei Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 53. Nikkiso Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 54. WEGO Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 55. Newsol Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 56. Mayo Clinic Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 57. Guangdong Biolight Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 58. Medtronic Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 59. Sanxin Medtec Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 60. Jafron Biomedical Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 61. SWS Hemodialysis Care Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 62. Tianyi Medical Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock